But the National Institutes of Health terminated research related to those latter groups, including Charlton’s, stating that President Donald Trump’s NIH director, Jay Bhattacharya, found such ...

MELBOURNE, Australia and SYDNEY, Sept. 29, 2019 /PRNewswire/ -- Kinoxis Therapeutics Pty Ltd, a pre-clinical stage biotechnology company developing novel therapies for substance use disorders and ...

An article published in the Journal of the American Medical Association highlights the results of numerous strategies through which the National Institutes of Health's Helping to End Addiction ...

In a letter to NIH Director Jay Bhattacharya on Monday, NIH workers said they felt “compelled to speak up" about research ...

A group of scientists and health groups sued the National Institutes of Health on Wednesday, arguing that an "ideological purge" of research funding is illegal and threatens medical cures.

Brixton Biosciences, a clinical-stage life sciences company, today announced it has been awarded first-year funding of a $2 million grant from the National Institutes of Health (NIH) through the ...